Peculiarities of Most Commonly Used Chemotherapy Drugs in Neonates and Infants

  • Carolina Witchmichen Penteado Schmidt


This description of drugs, doses, and other information is provided for study. Broad knowledge of the drug, the protocol (drug dosages vary a lot according to different protocols), toxicity, dose adjustment, patient monitoring, and other pertinent aspects is necessary before prescribing.


  1. 4.
    Taketomo C, Hodding J, Kraus D. Pediatric & neonatal dosage handbook. 21st ed. Hudson: Lexicomp; 2014.Google Scholar
  2. 1.
    Schmidt CWP, Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2016.Google Scholar
  3. 47.
    McLeod HL, Relling MV, Crom WR, et al. Disposition of antineoplastic drugs agents in the very young child. Br J Cancer Suppl. 1992;18:S23–9.PubMedPubMedCentralGoogle Scholar
  4. 71.
    Veal GJ, Errington J, Hayden J, et al. Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer. 2015;51(14):2022–30.CrossRefGoogle Scholar
  5. 68.
    Veal GJ, Errington J, Sastry J, et al. Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer Chemother Pharmacol. 2016;77:685–92. CrossRefGoogle Scholar
  6. 45.
    Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. 2015;3:37.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Carolina Witchmichen Penteado Schmidt
    • 1
  1. 1.CuritibaBrazil

Personalised recommendations